Rosemary Mazanet's most recent trade in Oncternal Therapeutics Inc was a trade of 2,200 Stock Options done . Disclosure was reported to the exchange on June 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 20,000 | 20,000 | - | - | Stock Options | |
| Oncternal Therapeutics Inc | Rosemary Mazanet | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 30,000 | 30,000 | - | - | Stock Options |